Cart
sales@molnova.com
Meconin
CAS No. 569-31-3
Meconin( —— )
Catalog No. M28132 CAS No. 569-31-3
Meconin is a noscapine metabolite and a useful adjunct in detecting illicit opiate use.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 32 | In Stock |
|
| 25MG | 51 | In Stock |
|
| 50MG | 75 | In Stock |
|
| 100MG | 110 | In Stock |
|
| 200MG | 160 | In Stock |
|
| 500MG | 267 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMeconin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMeconin is a noscapine metabolite and a useful adjunct in detecting illicit opiate use.
-
DescriptionMeconin is a noscapine metabolite and a useful adjunct in detecting illicit opiate use.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorSIRT1|Antiviral
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number569-31-3
-
Formula Weight194.186
-
Molecular FormulaC10H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (514.99 mM)
-
SMILESCOc1ccc2COC(=O)c2c1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Thomas Shenk, et al. Sirtuin Modulators as Inhibitors of Cytomegalovirus. US20160296523A1.
molnova catalog
related products
-
Sphingosine-1-phosph...
Sphingosine-1-phosphate (S1P) is an agonist for S1P1-5 receptors and a ligand for GPR3, GPR6, and GPR12. As an intracellular second messenger, it mobilizes Ca2+ and acts as an extracellular ligand for G-protein coupled receptors.
-
3-Amino-4-methylpent...
Beta-leucine?is a beta-amino acid that is?pentanoic acid?substituted at positions 3 and 4 by?amino?and?methyl?groups respectively. It has a role as a human metabolite.
-
Glycerol
Glycerol or glycerin is a colourless odourless viscous liquid that is sweet-tasting and mostly non-toxic. It is widely used in the food industry as a sweetener and humectant and in pharmaceutical formulations.
